Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 8-K, Date: 2010-04-28
Original SEC Filing: Click here

---

Webplus: BSPM/20100428/8-K/2_EX-99.1/000.htm SEC Original: ex99-1.htm
BIOSTAR PHARMACEUTICALS, RECEIVES NEWVERTISING APPROVAL FROM SHAANXI SFDA FOR MARKETING XIN AOXINGPSULE XIANYANG, China, April 27, 2010 (Xinhua-PRNewswire-FirstCall) On April 22, 2010 the Shaanxi SFDA published on its website a notification stating that the marketing language used innnection with several pharmaceutical products sold in the province are not within approved parameters.Biostar Pharmaceuticals flagship Hepatitis B

---

---

Webplus: BSPM/20100428/8-K/1/000.htm SEC Original: biostar8k042710.htm
FORM 8-K CURRENT REPORTte of report (Date of earliest event reported): April 27, 2010 BIOSTAR PHARMACEUTICALS, Maryland 333-147363 20-5101287 (State or other jurisdiction oforporation or organization) (Commission File No.) (IRS Employer Identification No.) No. 588 Shiji Avenue Xiangyang City, Shaanxi Province Peoples Republic of China 712046 86-029-33686638 (Issuer Telephone Number)

---

Company Information:

Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 8-K, Date: 2010-04-28CIK: 0001418133, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 588 SHIJI XI AVENUE
XIANYANG, SHAANXI PROVINCE 712046